David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Assertio $70 million convertible senior notes offering
The 6.5% notes are due 2027
Bloom Energy $388.7 million follow-on offering
The shares are listed on the NYSE
Oak Street Health $180.3 million secondary offering
We advised the joint book-running managers on the equity offering
Tenaya Therapeutics $75 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Arrival $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market